Ken Griffin acquired 1.39 Million Ventyx Biosciences shares worth $2.9 Million. That's 0.00% of their equity portfolio (2067th largest holding). The investor owns 1.95% of the outstanding Ventyx Biosciences stock. The first Ventyx Biosciences trade was made in Q4 2021. Since then Ken Griffin bought shares six more times and sold shares on seven occasions. The investor's estimated purchase price is $20.5 Million, resulting in a loss of 86%.